Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors

Clinical trial NCT05824494 · UNKNOWN

Trial details

NCT number: NCT05824494
Sponsor: Women's Hospital School Of Medicine Zhejiang University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Uterine Cervical Neoplasms Cancer of Cervix Cervical Cancer Cervical Neoplasms Uterine Cervical Cancer Cancer of the Uterine Cervix

Start date: 2023-06-01
Primary completion: 2026-06-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.